共 50 条
- [1] A Randomized, Double-Blind, Placebo-Controlled Study of Venetoclax with Azacitidine Versus Azacitidine in Treatment-Naive Patients with Acute Myeloid Leukemia Ineligible for Intensive Therapy-Viale-ACLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S179 - S179DiNardo, Courtney D.Jonas, Brian A.Pullarkat, VinodThirman, Michael J.Garcia, Jacqueline S.Wei, Andrew H.Doehner, HartmutFenaux, PierreRecher, ChristianKonopleva, MarinaFiedler, WalterKoller, ElisabethHavelange, ViolaineSchuh, Andre C.Esteve, JordiWang, JianxiangVrhovac, RadovanHajek, RomanPorkka, KimmoIlles, ArpadWolach, OfirOlivieri, AttilioYamamoto, KazuhitoJang, Jun-HoJuliusson, GunnarVorobyev, VladimirYeh, Su-PengOzcan, MuhitHong, Wan-JenZhou, YingPotluri, JalajaPratz, Keith W.
- [2] Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemiaBLOOD, 2019, 133 (01) : 7 - 17DiNardo, Courtney D.Pratz, KeithPullarkat, VinodJonas, Brian A.Arellano, MarthaBecker, Pamela S.Frankfurt, OlgaKonopleva, MarinaWei, Andrew H.Kantarjian, Hagop M.Xu, TuHong, Wan-JenChyla, BrendaPotluri, JalajaPollyea, Daniel A.Letai, Anthony
- [3] A Phase I Study of Uproleselan Combined with Azacitidine and Venetoclax for the Treatment of Older or Unfit Patients with Treatment Naive Acute Myeloid LeukemiaBLOOD, 2022, 140 : 6213 - 6214Jonas, Brian A.Welborn, Jeanna L.Esteghamat, Naseem S.Hoeg, Rasmus T.Rosenberg, Aaron S.Molnar, LauraDang-Chu, Ashley LinhStewart, Susan L.Tuscano, Joseph M.
- [4] Reduced Venetoclax Exposition to Seven Days of Azacitidine Is Efficient in Treatment-Naive Patients with Acute Myeloid LeukemiaBLOOD, 2022, 140Willekens, ChristopheChraibi, SamyDecroocq, JustineCarpentier, BenjaminLebon, DelphineBonnet, SarahGauthier, NicolasPages, ArnaudDragani, MatteoKhalife-Hachem, SabineMicol, Jean-BaptistePasquier, FlorenceWickenhauser, StefanSaada, VeroniqueVerge, VeroniqueArbab, AhmadrezaMarzac, ChristophePascal, LaurentRoos-Weil, DamienJourdan, EricBouscary, Didierde Botton, Stephane
- [5] Updated Safety and Efficacy of Venetoclax with Decitabine or Azacitidine in Treatment-Naive, Elderly Patients with Acute Myeloid LeukemiaBLOOD, 2017, 130DiNardo, Courtney D.Pollyea, Daniel A.Jonas, Brian A.Konopleva, MarinaPullarkat, VinodWei, AndrewKantarjian, Hagop M.Pigneux, ArnaudRecher, ChristianSeymour, John F.Dunbar, MartinXu, TuMabry, MackPotluri, JalajaPratz, KeithLetai, Anthony
- [6] AGILE: A Global, Randomized, Double-Blind, Phase 3 Study of Ivosidenib plus Azacitidine Versus Placebo plus Azacitidine in Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 MutationBLOOD, 2021, 138Montesinos, PauRecher, ChristianVives, SusanaZarzycka, EwaWang, JianxiangBertani, GiambattistaHeuser, MichaelCalado, Rodrigo T.Schuh, Andre C.Yeh, Su-PengDaigle, Scott R.Hui, JiananZhang, VickiePandya, Shuchi S.Gianolio, Diego A.de Botton, StephaneDoehner, Hartmut
- [7] AGILE: A Global, Randomized, Double-Blind, Phase 3 Study of Ivosidenib plus Azacitidine Versus Placebo plus Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 MutationCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S234 - S234Dohner, HartmutMontesinos, PauPolo, Susana VivesZarzycka, EwaWang, JianxiangBertani, GiambattistaHeuser, MichaelCalado, Rodrigo T.Schuh, Andre C.Yeh, Su-Pengde la Fuente, AdolfoCerchione, ClaudioDaigle, Scott R.Hui, JiananPandya, Shuchi S.Gianolio, Diego A.Recher, Christiande Botton, Stephane
- [8] Impact of FLT3 Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naive Acute Myeloid LeukemiaCLINICAL CANCER RESEARCH, 2022, 28 (13) : 2744 - 2752Konopleva, MarinaThirman, Michael J.Pratz, Keith W.Garcia, Jacqueline S.Recher, ChristianPullarkat, VinodKantarjian, Hagop M.DiNardo, Courtney D.Dail, MoniqueDuan, YinghuiChyla, BrendaPotluri, JalajaMiller, Catherine L.Wei, Andrew H.
- [9] Measurable Residual Disease Response and Prognosis in Treatment-Naive Acute Myeloid Leukemia With Venetoclax and AzacitidineJOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (08) : 855 - +Pratz, Keith W.Jonas, Brian A.Pullarkat, VinodRecher, ChristianSchuh, Andre C.Thirman, Michael J.Garcia, Jacqueline S.DiNardo, Courtney D.Vorobyev, VladimirFracchiolla, Nicola S.Yeh, Su-PengJang, Jun HoOzcan, MuhitYamamoto, KazuhitoIlles, ArpadZhou, YingDail, MoniqueChyla, BrendaPotluri, JalajaDoehner, Hartmut
- [10] Impact of Venetoclax and Azacitidine in Treatment-Naive Patients with Acute Myeloid Leukemia and IDH1/2 MutationsCLINICAL CANCER RESEARCH, 2022, 28 (13) : 2753 - 2761Pollyea, Daniel A.DiNardo, Courtney D.Arellano, Martha L.Pigneux, ArnaudFiedler, WalterKonopleva, MarinaRizzieri, David A.Smith, B. DouglasShinagawa, AtsushiLemoli, Roberto M.Dail, MoniqueDuan, YinghuiChyla, BrendaPotluri, JalajaMiller, Catherine L.Kantarjian, Hagop M.